119 related articles for article (PubMed ID: 25435270)
41. Clinical implication of PET/MR imaging in preoperative esophageal cancer staging: comparison with PET/CT, endoscopic ultrasonography, and CT.
Lee G; I H; Kim SJ; Jeong YJ; Kim IJ; Pak K; Park DY; Kim GH
J Nucl Med; 2014 Aug; 55(8):1242-7. PubMed ID: 24868109
[TBL] [Abstract][Full Text] [Related]
42. Integrated PET/CT fusion imaging and endoscopic ultrasound in the pre-operative staging and evaluation of esophageal cancer.
Walker AJ; Spier BJ; Perlman SB; Stangl JR; Frick TJ; Gopal DV; Lindstrom MJ; Weigel TL; Pfau PR
Mol Imaging Biol; 2011 Feb; 13(1):166-71. PubMed ID: 20379789
[TBL] [Abstract][Full Text] [Related]
43. Endoscopic ultrasound in the staging of tumours of the oesophagus and gastro-oesophageal junction.
Richards DG; Brown TH; Manson JM
Ann R Coll Surg Engl; 2000 Sep; 82(5):311-7. PubMed ID: 11041028
[TBL] [Abstract][Full Text] [Related]
44. Routine positron emission tomography does not alter nodal staging in patients undergoing EUS-guided FNA for esophageal cancer.
Keswani RN; Early DS; Edmundowicz SA; Meyers BF; Sharma A; Govindan R; Chen J; Kohlmeier C; Azar RR
Gastrointest Endosc; 2009 Jun; 69(7):1210-7. PubMed ID: 19012886
[TBL] [Abstract][Full Text] [Related]
45. The utility of FDG-PET in the preoperative staging of esophageal cancer.
Gananadha S; Hazebroek EJ; Leibman S; Berry H; Osgood L; Shon IH; Pavlakis N; Marx G; Smith GS
Dis Esophagus; 2008; 21(5):389-94. PubMed ID: 19125791
[TBL] [Abstract][Full Text] [Related]
46. [Imaging of cancer of the esophagus: ultrasound-endoscopy or computed tomography?].
Fékété F; Sauvanet A; Zins M; Berthoux L; Amouyal G
Ann Chir; 1995; 49(7):573-8; discussion 578-9. PubMed ID: 8554267
[TBL] [Abstract][Full Text] [Related]
47. Comparison of (18)F-fluorothymidine and (18)F-fluorodeoxyglucose PET/CT in delineating gross tumor volume by optimal threshold in patients with squamous cell carcinoma of thoracic esophagus.
Han D; Yu J; Yu Y; Zhang G; Zhong X; Lu J; Yin Y; Fu Z; Mu D; Zhang B; He W; Huo Z; Liu X; Kong L; Zhao S; Sun X
Int J Radiat Oncol Biol Phys; 2010 Mar; 76(4):1235-41. PubMed ID: 19910143
[TBL] [Abstract][Full Text] [Related]
48. Endoscopic ultrasound: impact on survival in patients with esophageal cancer.
Schrager JJ; Tarpley JL; Smalley WE; Austin MT; Pearson AS
Am J Surg; 2005 Nov; 190(5):682-6. PubMed ID: 16226939
[TBL] [Abstract][Full Text] [Related]
49. Has integrated 18F FDG PET/CT improved staging, reduced early recurrence or increased survival in oesophageal cancer?
Torrance AD; Almond LM; Fry J; Wadley MS; Lyburn ID
Surgeon; 2015 Feb; 13(1):19-33. PubMed ID: 24206935
[TBL] [Abstract][Full Text] [Related]
50. [Radiotherapy volume delineation based on (
Encaoua J; Abgral R; Leleu C; El Kabbaj O; Caradec P; Bourhis D; Pradier O; Schick U
Cancer Radiother; 2017 Jun; 21(4):267-275. PubMed ID: 28499658
[TBL] [Abstract][Full Text] [Related]
51. A prospective evaluation of staging and target volume definition of lymph nodes by 18FDG PET/CT in patients with squamous cell carcinoma of thoracic esophagus.
Yu W; Fu XL; Zhang YJ; Xiang JQ; Shen L; Chang JY
Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):e759-65. PubMed ID: 21470788
[TBL] [Abstract][Full Text] [Related]
52. Impact of EUS-FNA in the management of patients with oesophageal cancer.
Morris JM; Suzuki H; McKernan M; Stephen M; Stuart RC; Stanley AJ
Scott Med J; 2009 May; 54(2):30-3. PubMed ID: 19530500
[TBL] [Abstract][Full Text] [Related]
53. Determination of regional lymph node status using (18)F-FDG PET/CT parameters in oesophageal cancer patients: comparison of SUV, volumetric parameters and intratumoral heterogeneity.
Kim SJ; Pak K; Chang S
Br J Radiol; 2016; 89(1058):20150673. PubMed ID: 26607643
[TBL] [Abstract][Full Text] [Related]
54. Lymph node staging in esophageal squamous cell carcinoma: a comparative study of endoscopic ultrasonography versus computed tomography.
Takizawa K; Matsuda T; Kozu T; Eguchi T; Kato H; Nakanishi Y; Hijikata A; Saito D
J Gastroenterol Hepatol; 2009 Oct; 24(10):1687-91. PubMed ID: 19788609
[TBL] [Abstract][Full Text] [Related]
55. Loco-regional staging accuracy in oesophageal cancer-How good are we in the modern era?
Bunting D; Bracey T; Fox B; Berrisford R; Wheatley T; Sanders G
Eur J Radiol; 2017 Dec; 97():71-75. PubMed ID: 29153370
[TBL] [Abstract][Full Text] [Related]
56. Metabolic tumor volume provides complementary prognostic information to EUS staging in esophageal and junctional cancer.
Malik V; Johnston C; O'Toole D; Lucey J; O'Farrell N; Claxton Z; Reynolds JV
Dis Esophagus; 2017 Feb; 30(3):1-8. PubMed ID: 27862622
[TBL] [Abstract][Full Text] [Related]
57. Accuracy of contemporary oesophageal cancer lymph node staging with radiological-pathological correlation.
Foley KG; Christian A; Fielding P; Lewis WG; Roberts SA
Clin Radiol; 2017 Aug; 72(8):693.e1-693.e7. PubMed ID: 28363659
[TBL] [Abstract][Full Text] [Related]
58. The decision to operate: role of integrated computed tomography positron emission tomography in staging oesophageal and oesophagogastric junction cancer by the multidisciplinary team.
Berrisford RG; Wong WL; Day D; Toy E; Napier M; Mitchell K; Wajed S
Eur J Cardiothorac Surg; 2008 Jun; 33(6):1112-6. PubMed ID: 18328726
[TBL] [Abstract][Full Text] [Related]
59. [Correlation between PET-CT 18FDG uptake in primary lesions and clinicopathological parameters in esophageal carcinoma patients].
Feng R; Li MH; Kong L; Shi F; Yang GR; Yu JM
Zhonghua Zhong Liu Za Zhi; 2009 Jun; 31(6):452-4. PubMed ID: 19950557
[TBL] [Abstract][Full Text] [Related]
60. Whole tumour quantitative measurement of first-pass perfusion of oesophageal squamous cell carcinoma using 64-row multidetector computed tomography: correlation with microvessel density.
Chen TW; Yang ZG; Wang QL; Li Y; Qian LL; Chen HJ
Eur J Radiol; 2011 Aug; 79(2):218-23. PubMed ID: 20399055
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
